R. W. Hoffmann, D. Stenkamp, T. Trieselmann, R. Göttlich
127.5, 127.8, 128.3, 138.7. Ϫ C12H17ClO (212.7): calcd. C 67.76, H 7.7, and 6.4 Hz, 1 H), 2.92 (s, 3 H), 3.61 (m, 1 H), 4.39 (d, J ϭ
FULL PAPER
8.06; found C 67.49, H 7.76.
11.7 Hz, 1 H), 4.59 (d, J ϭ 11.7 Hz, 1 H), 4.93 (m, 1 H), 7.25Ϫ7.34
(m, 5 H). Ϫ 13C NMR (100 MHz, CDCl3): δ ϭ 19.4, 21.1, 38.4,
43.6, 70.1, 71.1, 77.6, 127.5, 127.6, 128.3, 138.3. Ϫ C13H20O4S
(272.4): calcd. C 57.33, H 7.40; found C 57.48, H 7.67.
9. (2R*,4R*)-2-Benzyloxy-4-bromopentane (12d): CBr4 (229 mg,
0.69 mmol) was added to a solution of (2S*,4R*)-4-benzyloxy-2-
pentanol (18, 96 mg, 0.49 mmol) in dichloromethane (0.4 mL). The
solution was cooled to Ϫ20°C and a solution of triphenylphos-
13. (2R*,4R*)-2-Azido-4-benzyloxypentane (12k): Sodium azide (46
phane (181 mg, 0.69 mmol) in dichloromethane (1.0 mL) was ad- mg, 0.70 mmol) was added to a solution of (1R*,3S*)-3-benzyloxy-
ded dropwise. After 1 d at room temperature, silica gel (0.7 g) was
added and the mixture was concentrated. The residue was purified
by flash chromatography using pentane and 0.7% tert-butyl methyl
ether in pentane to furnish the product 12d (105 mg, 88%) as a
colorless oil. Ϫ 1H NMR (500 MHz, CDCl3): δ ϭ 1.24 (d, J ϭ 6.1
1-methyl-butyl methanesulfonate (20) (147 mg, 0.54 mmol) in di-
methylformamide (1.8 mL). The mixture was stirred for 12 h at
50°C. Saturated aqueous NaHCO3 solution (3 mL) was added and
the phases were separated. The aqueous phase was extracted with
tert-butyl methyl ether (2 ϫ 30 mL) and the combined organic
Hz, 3 H), 1.72 (d, J ϭ 6.7 Hz, 3 H), 1.84 (ddd, J ϭ 15.0, 10.4, and phases were washed with brine (10 mL), dried (MgSO4) and con-
3.0 Hz, 1 H), 1.90 (ddd, J ϭ 15.0, 9.4, and 3.2 Hz, 1 H), 3.86 (m,
1 H), 4.45 (m, 1 H), 4.46 (d, J ϭ 11.3 Hz, 1 H), 4.64 (d, J ϭ 11.2
centrated. Flash chromatography of the residue (134 mg) with pen-
tane and 1.5% tert-butyl methyl ether in pentane furnished the
Hz, 1 H), 7.28Ϫ7.37 (m, 5 H). Ϫ 13C NMR (75 MHz, CDCl3): product 12k (99 mg, 84%) as a colorless oil. Ϫ 1H NMR (300 MHz,
δ ϭ 19.5, 27.0, 48.9, 49.0, 71.3, 73.5, 127.6, 127.9, 128.4, 138.7. Ϫ
C12H17BrO (257.2): calcd. C 56.05, H 6.66; found C 56.34, H 6.70.
CDCl3): δ ϭ 1.12 (d, J ϭ 6.1 Hz, 3 H), 1.16 (d, J ϭ 6.6 Hz, 3 H),
1.39 (ddd, J ϭ 14.4, 10.4, and 3.0 Hz, 1 H), 1.55 (ddd, J ϭ 14.4,
9.9, and 3.3 Hz, 1 H), 3.66 (m, 2 H), 4.33 (d, J ϭ 11.3 Hz, 1 H),
4.53 (d, J ϭ 11.3 Hz, 1 H), 7.18Ϫ7.28 (m, 5 H). Ϫ 13C NMR (75
MHz, CDCl3): δ ϭ 19.7, 20.1, 44.3, 55.0, 70.8, 71.8, 127.6, 127.8,
128.3, 138.6. Ϫ C12H17N3O (219.3): calcd. C 65.73, H 7.81, N
19.16; found C 65.50, H 8.00, N 19.11.
10. (2R*,4R*)-2-Benzyloxy-4-phthalimidopentane (12j): Phthali-
mide (106 mg, 0.72 mmol) and triphenylphosphane (180 mg, 0.68
mmol) were added sequentially at 0°C to a solution of (2S*,4R*)-
4-benzyloxy-2-pentanol (18) (100 mg, 0.51 mmol) in THF (2.6 mL).
After cooling to 0°C diethyl azodicarboxylate (105 µL, 0.67 mmol)
was added dropwise, the mixture was allowed to reach room tem-
perature. After 12 h, silica gel (0.7 g) was added and the suspension
was concentrated. Flash chromatography of the residue with pen-
tane and 10% tert-butyl methyl ether in pentane furnished the prod-
14. (2R*,4R*)-2-Benzyloxy-4-(phenylthio)pentane (12b): n-Butyl-
lithium (1.36 in hexane, 0.86 mmol) was added dropwise at
Ϫ78°C to a solution of thiophenol (103 µL, 1.0 mmol) in THF
(2.0 mL). After stirring for 20 min at Ϫ78°C, a solution of (1R*,
uct 12j (141 mg, 86%) as a colorless oil. Ϫ 1H NMR (500 MHz, 3S*)-3-benzyloxy-1-methylbutyl methanesulfonate (20) (151 mg,
CDCl3): δ ϭ 1.20 (d, J ϭ 6.1 Hz, 3 H), 1.45 (d, J ϭ 7.0 Hz, 3 H),
1.79 (ddd, J ϭ 14.6, 9.4, and 3.8 Hz, 1 H), 2.46 (ddd, J ϭ 14.6,
0.58 mmol) in THF (1.0 mL) was added by means of a canula. The
solution was allowed to stir for 36 h at room temperature. Saturated
11.0, and 2.8 Hz, 1 H), 3.40 (m, 1 H), 4.28 (d, J ϭ 10.9 Hz, 1 H), aqueous NaHCO3 solution (5 mL) was added and the phases were
4.44 (d, J ϭ 10.9 Hz, 1 H), 4.75 (m, 1 H), 7.18Ϫ7.34 (m, 5 H), separated. The aqueous phase was extracted with tert-butyl methyl
7.66 (m, 2 H), 7.78 (m, 2 H). Ϫ 13C NMR (75 MHz, CDCl3): δ ϭ ether (2 ϫ 30 mL). The combined organic phases were washed with
19.25, 19.31, 40.5, 43.9, 70.8, 72.2, 122.9, 127.3, 127.9, 128.1, 132.0,
brine (10 mL), dried (MgSO4), and concentrated. Flash chromatog-
133.6, 138.4, 168.4. Ϫ C20H21NO3 (323.4): calcd. C 74.28, H 6.55, raphy of the residue with pentane and 2% tert-butyl methyl ether
N 4.33; found C 74.22, H 6.73, N 4.64.
in pentane furnished the product 12b (137 mg, 83%) as a colorless
oil. Ϫ 1H NMR (300 MHz, CDCl3): δ ϭ 1.21 (d, J ϭ 6.0 Hz, 3
H), 1.29 (d, J ϭ 6.8 Hz, 3 H), 1.60 (ddd, J ϭ 14.5, 9.6, and 3.6
Hz, 1 H), 1.81 (ddd, J ϭ 14.5, 9.2, and 4.6 Hz, 1 H), 3.48 (m, 1
H), 3.89 (m, 1 H), 4.36 (d, J ϭ 11.4 Hz, 1 H), 4.58 (d, J ϭ 11.4
Hz, 1 H), 7.20Ϫ7.38 (m, 10 H). Ϫ 13C NMR (75 MHz, CDCl3):
δ ϭ 19.8, 22.7, 40.5, 44.7, 70.8, 72.9, 126.6, 127.4, 127.8, 128.3,
128.7, 132.0, 135.3, 138.9. Ϫ C18H22OS (286.4): calcd. C 75.48, H
7.74; found C 75.20, H 7.62.
11. (2R*,4S*)-2-Benzyloxy-4-phthalimidopentane (19): (2S*,4S*)-4-
Benzyloxy-2-pentanol (17, 400 mg, 2.06 mmol) was allowed to re-
act with phthalimide (424 mg, 2.88 mmol) and triphenylphosphane
(718 mg, 2.74 mmol) essentially as described under 10. to give 19
1
(570 mg, 86%) as a colorless oil. Ϫ H NMR (300 MHz, CDCl3):
δ ϭ 1.21 (d, J ϭ 6.1 Hz, 3 H), 1.42 (d, J ϭ 7.0 Hz, 3 H), 1.84
(ddd, J ϭ 14.1, 5.9, and 5.1 Hz, 1 H), 2.41 (ddd, J ϭ 14.2, 8.8, and
7.9 Hz, 1 H), 3.51 (m, 1 H), 4.27 (d, J ϭ 11.7 Hz, 1 H), 4.48 (d,
J ϭ 11.6 Hz, 1 H), 4.54 (m, 1 H), 7.08Ϫ7.16 (m, 5 H), 7.57Ϫ7.63 15. (2R*,4S*)-4-Phthalimido-2-pentanol (21): Palladium hydroxide
(m, 2 H), 7.67Ϫ7.73 (m, 2 H). Ϫ 13C NMR (75 MHz, CDCl3): δ ϭ
on carbon (20%, 13 mg) was added to a solution of (2S*,4R*)-2-
18.8, 19.6, 40.3, 44.8, 70.0, 72.9, 122.8, 127.0, 127.3, 128.0, 132.0, benzyloxy-4-phthalimidopentane (19) (567 mg, 1.75 mmol) in
133.5, 138.5, 168.3. Ϫ C20H21NO3 (323.4): calcd. C 74.28, H 6.55, methanol (17.5 mL). The mixture was stirred for 20 h under hydro-
N 4.33; found C 74.19, H 6.46, N 4.57.
gen. The mixture was filtered through a pad of Kieselgur and the
filtrate was concentrated. The residue (408 mg) was purified by
flash chromatography with gradients of petroleum ether and tert-
butyl methyl ether varying from 4:1 to 1:2, giving the product 21
12. (1R*,3S*)-3-Benzyloxy-1-methylbutyl Methanesulfonate (20):
Triethylamine (0.38 mL, 2.37 mmol) was added at Ϫ20°C to a solu-
tion of (2S*,4R*)-4-benzyloxy-2-pentanol (18) (408 mg, 2.10
mmol) in dichloromethane (8.4 mL). Methanesulfonyl chloride
(0.19 mL, 2.42 mmol) was added and the solution was stirred for
25 min at room temperature. Saturated aqueous NaHCO3 solution
(10 mL) was added and the phases were separated. The aqueous
phase was extracted with tert-butyl methyl ether (3 ϫ 30 mL), the
combined organic phases were washed with brine (20 mL) and
dried (MgSO4). Concentration of the solution furnished the prod-
1
(387 mg, 95%) as a colorless oil. Ϫ H NMR (300 MHz, CDCl3):
δ ϭ 1.21 (d, J ϭ 6.2 Hz, 3 H), 1.43 (s, 1 H), 1.49 (d, J ϭ 7.0 Hz,
3 H), 1.89 (ddd, J ϭ 14.1, 6.3, and 4.7 Hz, 1 H), 2.18 (dt, J ϭ 14.1
and 8.4 Hz, 1 H), 3.83 (m, 1 H), 4.53 (m, 1 H), 7.66Ϫ7.69 (m, 2
H), 7.78Ϫ7.81 (m, 2 H). Ϫ 13C NMR (75 MHz, CDCl3): δ ϭ 18.7,
24.1, 42.6, 45.0, 66.3, 123.0, 132.1, 133.8, 168.6. Ϫ C13H15NO3
(233.3): calcd. C 66.94, H 6.48, N 6.00; found C 66.72, H 6.32,
N 6.27.
1
uct 20 (572 mg, 100%) as a colorless oil. Ϫ H NMR (300 MHz,
CDCl3): δ ϭ 1.26 (d, J ϭ 6.1 Hz, 3 H), 1.37 (d, J ϭ 6.3 Hz, 3 H), 16. (2R*,4R*)-2,4-Bis(phthalimido)pentane (2e): (2R*,4S*)-4-
1.67 (ddd, J ϭ 14.1, 6.9, and 5.2 Hz, 1 H), 2.11 (ddd, J ϭ 14.1,
Phthalimido-2-pentanol (21, 125 mg, 0.54 mmol), phthalimide (118
2922
Eur. J. Org. Chem. 1999, 2915Ϫ2927